Seroprevalence of pertussis amongst healthcare professionals in Spain |
| |
Affiliation: | 1. Hospital Universitario Puerta de Hierro, C/Joaquín Rodrigo 2, Majadahonda, 28222 Madrid, Spain;2. Complejo Hospitalario Universitario, Xubias de Arriba 84, 15006 A Coruña, Spain;3. IDIBELL; Hospital Universitario de Bellvitge, Feixa Llarga s/n, Hospitalet Llobregat, 08907 Barcelona, Spain;4. Department of Microbiology, Facultad de Medicina, Av Blasco Ibañez 17, 46010 Valencia, Spain;5. Instituto Valenciano de Microbiología, Bétera, 46117 Valencia, Spain;6. GSK Pharmaceuticals Pvt. Ltd., CDOC-B, #5 Embassy Links, S.R.T. Road, 560052 Bangalore, India;7. GSK Vaccines, C/Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain;8. GSK Vaccines, Avenue Fleming 20, 1300 Wavre, Belgium |
| |
Abstract: | IntroductionThis multi-center, hospital-based observational study determined the seroprevalence of pertussis antibodies amongst healthcare professionals from three different hospitals in Spain to ascertain the health status of professionals attending to susceptible groups who are at risk of contracting and transmitting pertussis.MethodsMedical professionals from three hospitals in Spain were recruited for this study (NCT01706224). Serum samples from subjects were assessed for anti-pertussis antibodies by ELISA. The percentage of subjects positive for anti-pertussis antibodies were determined by age-strata, gender, vaccination status, professional level (physicians, nurses, ancillary nurses and midwives), hospital department, number of working years, numbers of hours spent with the patient as well as number of children in the household.ResultsOverall, 31.2% of subjects were seropositive; 3.3% of these healthcare professionals had ELISA values indicative of current or recent infection. There were no significant differences in terms of pertussis prevalence with respect to age, gender, hospital department, profession, number of working years and number of hours spent with patients. These levels of seronegativity amongst healthcare workers further strengthen the rationale for vaccination amongst this specific population against pertussis. |
| |
Keywords: | Seroprevalence Pertussis antibodies Healthcare professionals |
本文献已被 ScienceDirect 等数据库收录! |
|